MedTrace Logo

Smoking Cessation Programme in Workplaces in Hong Kong (Phase III)

NCT03142555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 679

Last updated 2021-09-21

No results posted yet for this study

Summary

Smoking causes cardiovascular and respiratory diseases, cancers and diabetes, and it has been a leading risk factor for death globally. Despite the availability of smoking cessation services locally, most smokers do not use such services. Workplace is one of the most convenient platforms to provide smoking cessation services and over 55% of smokers are employed according to the local population-based survey. However, the effectiveness of a smoking cessation programme conducted in workplace is yet to be examined in Hong Kong, and the attitudes and practices of corporations in promoting smoking cessation are not clear. Thus, this study aims to examine the employers'/managerial staff's knowledge, attitudes and practices in promoting smoking cessation in workplace and evaluate the smoking behaviours of participants before and after attending a smoking cessation intervention.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Health talk plus intensive social media intervention

Subjects in this group will receive treatments including a general health education talk about smoking cessation. Subjects will also get involved in the personalized what's app interaction (up to 2 months duration) to receive social support to quit smoking. The intervention outcomes and subjects' smoking status will be followed up regularly via telephone interviews (15 - 30 minutes).

BEHAVIORAL

Health talk plus less intensive social media intervention

Subjects in this group will receive treatments including a general health education talk about smoking cessation but without the information of active referral to other smoking cessation services. Subjects will receive less intensive reminders via social media. The intervention outcomes and subjects' smoking status will be followed up regularly via telephone interviews (15 - 30 minutes).

Sponsors & Collaborators

  • Lok Sin Tong Benevolent Society, Kowloon

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Tai Hing Lam, MD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-11
Primary Completion
2019-06-30
Completion
2021-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03142555 on ClinicalTrials.gov